Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 19
2004 10
2005 18
2006 27
2007 39
2008 36
2009 65
2010 93
2011 117
2012 156
2013 177
2014 159
2015 154
2016 164
2017 160
2018 161
2019 172
2020 213
2021 206
Text availability
Article attribute
Article type
Publication date

Search Results

2,151 results
Results by year
Filters applied: . Clear all
Page 1
Class effects of SGLT2 inhibitors on cardiorenal outcomes.
Kluger AY, Tecson KM, Lee AY, Lerma EV, Rangaswami J, Lepor NE, Cobble ME, McCullough PA. Kluger AY, et al. Cardiovasc Diabetol. 2019 Aug 5;18(1):99. doi: 10.1186/s12933-019-0903-4. Cardiovasc Diabetol. 2019. PMID: 31382965 Free PMC article. Review.
SGLT2i: beyond the glucose-lowering effect.
Ni L, Yuan C, Chen G, Zhang C, Wu X. Ni L, et al. Cardiovasc Diabetol. 2020 Jun 26;19(1):98. doi: 10.1186/s12933-020-01071-y. Cardiovasc Diabetol. 2020. PMID: 32590982 Free PMC article. Review.
Issues for the management of people with diabetes and COVID-19 in ICU.
Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Ceriello A, et al. Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2. Cardiovasc Diabetol. 2020. PMID: 32690029 Free PMC article. Review.
Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J, De Rosa S, Tammè L, Iaconetti C, Sorrentino S, Polimeni A, Mignogna C, Amorosi A, Spaccarotella C, Yasuda M, Indolfi C. Sabatino J, et al. Cardiovasc Diabetol. 2020 May 15;19(1):66. doi: 10.1186/s12933-020-01040-5. Cardiovasc Diabetol. 2020. PMID: 32414364 Free PMC article.
Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis.
Yamada T, Wakabayashi M, Bhalla A, Chopra N, Miyashita H, Mikami T, Ueyama H, Fujisaki T, Saigusa Y, Yamaji T, Azushima K, Urate S, Suzuki T, Abe E, Wakui H, Tamura K. Yamada T, et al. Cardiovasc Diabetol. 2021 Jan 7;20(1):14. doi: 10.1186/s12933-020-01197-z. Cardiovasc Diabetol. 2021. PMID: 33413348 Free PMC article.
2,151 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page